A simple HPLC method for the determination of halcinonide in lipid nanoparticles: development, validation, encapsulation efficiency, and in vitro drug permeation

ABSTRACT Halcinonide is a high-potency topical glucocorticoid used for skin inflammation treatments that presents toxic systemic effects. A simple and quick analytical method to quantify the amount of halcinonide encapsulated into lipid nanoparticles, such as polymeric lipid-core nanoparticles and solid lipid nanoparticles, was developed and validated regarding the drug's encapsulation efficiency and in vitro permeation. The development and validation of the analytical method were carried out using the high performance liquid chromatography with the UV detection at 239 nm. The validation parameters were specificity, linearity, precision and accuracy, limits of detection and quantitation, and robustness. The method presented an isocratic flow rate of 1.0 mL.min-1, a mobile phase methanol:water (85:15 v/v), and a retention time of 4.21 min. The method was validated according to international and national regulations. The halcinonide encapsulation efficiency in nanoparticles was greater than 99% and the in vitro drug permeation study showed that less than 9% of the drug permeated through the membrane, indicating a nanoparticle reservoir effect, which can reduce the halcinonide's toxic systemic effects. These studies demonstrated the applicability of the developed and validated analytical method to quantify halcinonide in lipid nanoparticles.

Saved in:
Bibliographic Details
Main Authors: Lopes,Clarissa Elize, Langoski,Gisele, Klein,Traudi, Ferrari,Priscileila Colerato, Farago,Paulo Vitor
Format: Digital revista
Language:English
Published: Universidade de São Paulo, Faculdade de Ciências Farmacêuticas 2017
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502017000200604
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1984-82502017000200604
record_format ojs
spelling oai:scielo:S1984-825020170002006042017-06-20A simple HPLC method for the determination of halcinonide in lipid nanoparticles: development, validation, encapsulation efficiency, and in vitro drug permeationLopes,Clarissa ElizeLangoski,GiseleKlein,TraudiFerrari,Priscileila ColeratoFarago,Paulo Vitor Halcinonide/encapsulation efficiency Halcinonide/quantification Polymeric lipid-core nanoparticles Solid lipid nanoparticles Topical administration Toxicity High performance liquid chromatography/method validation ABSTRACT Halcinonide is a high-potency topical glucocorticoid used for skin inflammation treatments that presents toxic systemic effects. A simple and quick analytical method to quantify the amount of halcinonide encapsulated into lipid nanoparticles, such as polymeric lipid-core nanoparticles and solid lipid nanoparticles, was developed and validated regarding the drug's encapsulation efficiency and in vitro permeation. The development and validation of the analytical method were carried out using the high performance liquid chromatography with the UV detection at 239 nm. The validation parameters were specificity, linearity, precision and accuracy, limits of detection and quantitation, and robustness. The method presented an isocratic flow rate of 1.0 mL.min-1, a mobile phase methanol:water (85:15 v/v), and a retention time of 4.21 min. The method was validated according to international and national regulations. The halcinonide encapsulation efficiency in nanoparticles was greater than 99% and the in vitro drug permeation study showed that less than 9% of the drug permeated through the membrane, indicating a nanoparticle reservoir effect, which can reduce the halcinonide's toxic systemic effects. These studies demonstrated the applicability of the developed and validated analytical method to quantify halcinonide in lipid nanoparticles.info:eu-repo/semantics/openAccessUniversidade de São Paulo, Faculdade de Ciências FarmacêuticasBrazilian Journal of Pharmaceutical Sciences v.53 n.2 20172017-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502017000200604en10.1590/s2175-97902017000215250
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Lopes,Clarissa Elize
Langoski,Gisele
Klein,Traudi
Ferrari,Priscileila Colerato
Farago,Paulo Vitor
spellingShingle Lopes,Clarissa Elize
Langoski,Gisele
Klein,Traudi
Ferrari,Priscileila Colerato
Farago,Paulo Vitor
A simple HPLC method for the determination of halcinonide in lipid nanoparticles: development, validation, encapsulation efficiency, and in vitro drug permeation
author_facet Lopes,Clarissa Elize
Langoski,Gisele
Klein,Traudi
Ferrari,Priscileila Colerato
Farago,Paulo Vitor
author_sort Lopes,Clarissa Elize
title A simple HPLC method for the determination of halcinonide in lipid nanoparticles: development, validation, encapsulation efficiency, and in vitro drug permeation
title_short A simple HPLC method for the determination of halcinonide in lipid nanoparticles: development, validation, encapsulation efficiency, and in vitro drug permeation
title_full A simple HPLC method for the determination of halcinonide in lipid nanoparticles: development, validation, encapsulation efficiency, and in vitro drug permeation
title_fullStr A simple HPLC method for the determination of halcinonide in lipid nanoparticles: development, validation, encapsulation efficiency, and in vitro drug permeation
title_full_unstemmed A simple HPLC method for the determination of halcinonide in lipid nanoparticles: development, validation, encapsulation efficiency, and in vitro drug permeation
title_sort simple hplc method for the determination of halcinonide in lipid nanoparticles: development, validation, encapsulation efficiency, and in vitro drug permeation
description ABSTRACT Halcinonide is a high-potency topical glucocorticoid used for skin inflammation treatments that presents toxic systemic effects. A simple and quick analytical method to quantify the amount of halcinonide encapsulated into lipid nanoparticles, such as polymeric lipid-core nanoparticles and solid lipid nanoparticles, was developed and validated regarding the drug's encapsulation efficiency and in vitro permeation. The development and validation of the analytical method were carried out using the high performance liquid chromatography with the UV detection at 239 nm. The validation parameters were specificity, linearity, precision and accuracy, limits of detection and quantitation, and robustness. The method presented an isocratic flow rate of 1.0 mL.min-1, a mobile phase methanol:water (85:15 v/v), and a retention time of 4.21 min. The method was validated according to international and national regulations. The halcinonide encapsulation efficiency in nanoparticles was greater than 99% and the in vitro drug permeation study showed that less than 9% of the drug permeated through the membrane, indicating a nanoparticle reservoir effect, which can reduce the halcinonide's toxic systemic effects. These studies demonstrated the applicability of the developed and validated analytical method to quantify halcinonide in lipid nanoparticles.
publisher Universidade de São Paulo, Faculdade de Ciências Farmacêuticas
publishDate 2017
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502017000200604
work_keys_str_mv AT lopesclarissaelize asimplehplcmethodforthedeterminationofhalcinonideinlipidnanoparticlesdevelopmentvalidationencapsulationefficiencyandinvitrodrugpermeation
AT langoskigisele asimplehplcmethodforthedeterminationofhalcinonideinlipidnanoparticlesdevelopmentvalidationencapsulationefficiencyandinvitrodrugpermeation
AT kleintraudi asimplehplcmethodforthedeterminationofhalcinonideinlipidnanoparticlesdevelopmentvalidationencapsulationefficiencyandinvitrodrugpermeation
AT ferraripriscileilacolerato asimplehplcmethodforthedeterminationofhalcinonideinlipidnanoparticlesdevelopmentvalidationencapsulationefficiencyandinvitrodrugpermeation
AT faragopaulovitor asimplehplcmethodforthedeterminationofhalcinonideinlipidnanoparticlesdevelopmentvalidationencapsulationefficiencyandinvitrodrugpermeation
AT lopesclarissaelize simplehplcmethodforthedeterminationofhalcinonideinlipidnanoparticlesdevelopmentvalidationencapsulationefficiencyandinvitrodrugpermeation
AT langoskigisele simplehplcmethodforthedeterminationofhalcinonideinlipidnanoparticlesdevelopmentvalidationencapsulationefficiencyandinvitrodrugpermeation
AT kleintraudi simplehplcmethodforthedeterminationofhalcinonideinlipidnanoparticlesdevelopmentvalidationencapsulationefficiencyandinvitrodrugpermeation
AT ferraripriscileilacolerato simplehplcmethodforthedeterminationofhalcinonideinlipidnanoparticlesdevelopmentvalidationencapsulationefficiencyandinvitrodrugpermeation
AT faragopaulovitor simplehplcmethodforthedeterminationofhalcinonideinlipidnanoparticlesdevelopmentvalidationencapsulationefficiencyandinvitrodrugpermeation
_version_ 1756437814272065536